Skip to Content
Center for International Blood and Marrow Transplant Research

LY19-01a

Main Content

Post-transplant cyclophosphamide-based haploidentical transplantation versus matched sibling or well matched unrelated donor transplantation for peripheral T-cell lymphoma: A CIBMTR lymphoma working committee and EBMT lymphoma working party analysis.

Study #: LY19-01a

Study Status: Published

Outcome of allogeneic transplantation for mature T-cell lymphomas: Impact of donor source and disease characteristics.

Citation

Hamadani M, Ngoya M, Sureda A, Bashir Q, Litovich CA, Finel H, Chen Y, Boumendil A, Zain J, Castagna L, Cashen AF, Blaise D, Shadman M, Pastano R, Khimani F, Arat M, Dietrich S, Schmitz N, Glass B, Kharfan-Dabaja MA, Corradini P, Sauter CS, Montoto S, Kwon M, Herrera AF, Dreger P.

Blood Advances. 2022, Feb 08: 6(3): 6(3):920-930. doi: 10.1182/bloodadvances.2021005899. Epub 2021, Dec 03. PMCID:PMC8945300.

PubMed

PMID: 34861680

Abstract